Eggshell Membrane Powder Market

How big is Eggshell Membrane Powder Market in 2026?

USD 2.1 Billion in 2026 and USD 8.8 Billion by 2036 at a 15.2% CAGR

Sales of eggshell membrane powder are estimated to grow at 15.2% from USD 2.1 billion in 2026 to USD 8.8 billion by 2036, up from USD 1.8 billion in 2025. Demand is moving beyond a generic collagen proposition because eggshell membrane naturally contains collagen, keratin and glycosaminoglycans, giving formulators a compact ingredient platform for joint, skin and broader wellness concepts. A 2025 randomized trial in women and a 2026 scientific review strengthened the commercial case for skin-focused and nutraceutical formulations.

The growth mechanism differs by country. Ingredient suppliers must match processing state, specifications and claims to the intended route of sale. The European Union authorized a defined enzymatically produced egg membrane hydrolysate as a novel food in July 2026, while Canada added chicken eggshell membranes to its non-novel food determinations in July 2026. The United States, Japan, South Korea and Australia use different frameworks for foods, supplements, functional products or listed medicines. This makes regulatory fit part of the buying decision alongside purity, solubility and batch consistency. Demand also benefits from the broader collagen ingredient market, as brands seek multifunctional inputs that support differentiated health positioning.

Key Takeaways of Eggshell Membrane Powder Market

• Demand is supported by a naturally occurring matrix of collagen and glycosaminoglycans that serves joint-health, beauty and formulated wellness applications.
• Conventional holds 59.6% of the Nature category in 2026, supported by established commercial processing routes and broader documented supply.
• Cosmetics & Personal Care leads Application with a 40.4% share in 2026 as beauty-from-within and skin-health concepts widen the ingredient's value proposition.
• Regulatory specificity remains a qualification gate because hydrolysis state, intended use, labeling and egg-allergen controls can change the commercial pathway.
• South Korea and Japan show the fastest profiled country growth at 22.1% and 21.7% CAGR, respectively, from 2026 to 2036.
• Profiled companies include Stratum Nutrition, ESM Technologies, Biova, Eggnovo, Kewpie Corporation, Certified Nutraceuticals and Seno Biotech.

Analyst Perspective

“Eggshell membrane powder moves from an interesting bioactive to a repeat-purchase ingredient when suppliers can connect composition, processing consistency and permissible claims in one technical package. The strongest commercial positions will come from grades that are easy for formulators to qualify across joint-health and beauty applications.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Eggshell Membrane Powder Market segmented?

Nature: Conventional, Organic. Application: Cosmetics & Personal Care, Nutraceutical, Food & Beverages, Pharmaceutical.

The eggshell membrane powder market is segmented by Nature into Conventional and Organic. Application is segmented into Cosmetics & Personal Care, Nutraceutical, Food & Beverages and Pharmaceutical. Nature shapes sourcing, certification and procurement expectations, while Application determines the required evidence package, dosage form, processing behavior and claims framework.

Why does Conventional lead demand within the Nature category?

Conventional grades hold the larger commercial position because industrial egg-processing streams provide a scalable raw-material base and several established suppliers already process chicken eggshell membrane into branded powders or hydrolyzed ingredients. Organic supply can support premium clean-label positioning, but it adds certification and chain-of-custody requirements across the egg source and membrane-processing stages. For buyers, the conventional route therefore offers a broader pool of documented specifications and established ingredient formats.

• Conventional holds 59.6% of the Nature category in 2026.
• In August 2025, Stratum Nutrition reported NutraStrong certification for NEM, OVOLUX and Eggshell Membrane Collagen Support Complex, showing how third-party quality documentation is being layered onto established conventional ingredient programs.

Why does Cosmetics & Personal Care lead demand within the Application category?

Cosmetics & Personal Care leads because eggshell membrane can be positioned at the intersection of collagen, skin structure and beauty-from-within. A randomized, double-blind trial published in 2025 reported improvements across several skin measures after oral eggshell membrane supplementation. That evidence gives ingredient suppliers a higher-value route into ingestible beauty concepts and complements the broader beauty-from-within category, where collagen remains a central formulation ingredient.

• Cosmetics & Personal Care holds 40.4% of the Application category in 2026.
• Beauty-focused formulations favor suppliers that can connect eggshell membrane identity with collagen content, hydrolysis state and a clearly defined substantiation package.

What are the drivers, restraints and opportunities in the Eggshell Membrane Powder Market?

Clinical evidence and upcycled multifunctionality support demand, while formulation qualification and end-use regulation slow conversion, and recent authorizations widen routes into food supplements and beauty applications.

• Driver: Published joint and skin evidence gives formulators multiple premium positioning routes from one membrane-derived ingredient.
• Restraint: Extraction method, hydrolysis state, solubility, allergen controls and country-specific claim rules raise the burden of supplier qualification.
• Opportunity: New regulatory clearances and better-characterized powders can expand use in supplements, functional foods and beauty-from-within products.

Eggshell membrane combines collagen with naturally occurring glycosaminoglycans and other structural proteins, which gives it a broader formulation story than a single-compound ingredient. The 2026 scientific review describes high-value applications across functional foods and nutraceuticals, while the 2025 skin trial supports a beauty-oriented route. This positions eggshell membrane within the broader functional ingredient market, where manufacturers increasingly value inputs that carry more than one substantiated health proposition.

Commercial qualification is more demanding than access to eggshell raw material. Separation, hydrolysis, drying and milling can alter solubility and composition, while egg-allergen management remains relevant across food and supplement applications. In the United States, FDA GRN No. 1194 for partially hydrolyzed eggshell membrane powder closed in February 2025 at the notifier's request. That status reinforces the need to match each commercial grade to the legal pathway and intended use rather than assume one specification works across foods, supplements and cosmetics.

Regulatory clarity can create a stronger route to market for well-characterized grades. Commission Implementing Regulation (EU) 2026/1427 authorized enzymatically produced egg membrane hydrolysate for adult food supplements at specified conditions, while Health Canada issued a 2026 non-novel determination for chicken eggshell membranes as food. These developments can reduce uncertainty for qualified products and encourage formulation work in premium supplements, ingestible beauty and selected functional foods.

Which country CAGRs are profiled in the Eggshell Membrane Powder Market?

Country	CAGR
South Korea	22.1%
Japan	21.7%
Germany	16.3%
Australia	16.0%
Russia	13.8%
France	12.9%
Canada	9.0%
USA	8.6%

How do country-level CAGRs compare in the Eggshell Membrane Powder Market?

The profiled rates form four distinct growth bands. South Korea and Japan are above 20%, Germany and Australia are around the mid-teens, Russia and France are in the low-to-mid teens, and Canada and the USA are below 10%. The 13.5 percentage-point spread between South Korea at 22.1% and the USA at 8.6% reflects different growth speeds rather than a ranking of absolute country market size.

• South Korea: Functional-ingredient recognition keeps safety, functionality and specification files central to commercialization.
• Japan: Foods with Function Claims places evidence and notification responsibility on the business operator, favoring well-documented ingredients.
• Germany: The 2026 EU novel-food authorization creates a clearer route for a defined egg membrane hydrolysate, while national supplement notification remains a separate step.
• Australia: Current ARTG listings show eggshell membrane powder in regulated listed medicines, supporting a visible route for joint-health formulations.
• Russia: Premarket state registration and continuing market oversight raise the operational importance of traceability and stable product documentation.
• France: EU novel-food rules interact with French controls on supplement composition, labeling and advertising.
• Canada: 2025 and 2026 licensing activity and the July 2026 non-novel food determination create multiple regulated routes for eggshell membrane use.
• USA: A developed ingredient-supplier base is balanced by different legal pathways for conventional foods, dietary supplements and cosmetics.

Country-wise Analysis

• South Korea has the fastest profiled growth rate at 22.1% CAGR from 2026 to 2036. The Ministry of Food and Drug Safety updated its rules for recognition of functional ingredients in 2026, keeping safety, functionality and specification evidence at the center of market entry. This favors eggshell membrane suppliers that can present a stable composition and a clear processing description rather than relying on a generic collagen identity. Local supplement companies can move faster when the raw-material dossier already aligns with the information required for functional-ingredient review.
• Japan is profiled at 21.7% CAGR from 2026 to 2036. The Foods with Function Claims system allows companies to market products with functional statements after submitting required safety and functionality information, but responsibility for the evidence remains with the business operator. This creates a natural advantage for suppliers that package technical data in a form that Japanese brand owners can use in notifications and consumer communication. Japan's established egg-processing base and adjacent food ingredient sectors support broad familiarity with egg-derived powders and associated handling requirements.
• Germany is profiled at 16.3% CAGR from 2026 to 2036. The July 2026 EU authorization of enzymatically produced egg membrane hydrolysate is commercially important because the authorization applies across the Union under defined conditions of use. Germany also requires food supplements to be notified to the Federal Office of Consumer Protection and Food Safety. Suppliers therefore need to separate ingredient eligibility from finished-product notification and provide customers with specifications that make that distinction easy to manage.
• Australia is profiled at 16.0% CAGR from 2026 to 2036. The Therapeutic Goods Administration listed MagZorb Joint Ease with NEM (ARTG 521559) in December 2025 and Youthology Glucosamine & Chondroitin (ARTG 529293), which contains eggshell membrane powder, in July 2026. These records show active use of the ingredient in listed medicines and make product quality, ingredient identity and sponsor documentation commercially relevant. Suppliers that can support consistent finished-product dossiers are better positioned for repeat orders from complementary-medicine brands.
• Russia is profiled at 13.8% CAGR from 2026 to 2036. Rospotrebnadzor stated in April 2026 that biologically active food supplements are controlled at the premarket state-registration stage and during circulation. For eggshell membrane powder, this raises the cost of changing raw-material specifications after launch because registration and market information need to remain aligned. Stable composition, traceable batches and dependable documentation can therefore carry more value than a lower-cost powder with variable characteristics.
• France is profiled at 12.9% CAGR from 2026 to 2036. The market benefits from the same 2026 EU novel-food authorization that applies in Germany, but finished-product execution is shaped by French rules on supplement presentation and advertising. DGCCRF guidance published in November 2025 stresses that supplements cannot be presented as preventing, treating or curing disease. Joint-health and skin-health brands therefore need precise wording, making supplier evidence useful not only for R&D but also for claim discipline and launch execution.
• Canada is profiled at 9.0% CAGR from 2026 to 2036. Health Canada added chicken eggshell membranes to its list of non-novel determinations in July 2026, while its licensed natural-health-product database includes products containing partially hydrolyzed chicken eggshell membrane with 2025 and 2026 licensing activity. The market therefore supports both food and natural-health-product routes, but each requires the correct product-specific compliance path. Suppliers that can transfer a clear ingredient dossier to brand owners reduce friction during formulation and licensing.
• The USA is profiled at 8.6% CAGR from 2026 to 2036. Domestic suppliers such as ESM Technologies and Biova support a developed commercial base for eggshell membrane ingredients, while FDA's 2025 closure of GRN No. 1194 shows that food-use status must be read at the specific notice and ingredient level. The opportunity remains broad across dietary supplements and beauty concepts, but formulators need use-specific review before carrying one raw-material specification across multiple categories. This demand sits alongside a much larger , which gives processors an established infrastructure for handling and commercializing egg-derived dry ingredients.

Who are the notable companies in the Eggshell Membrane Powder Market?

Stratum Nutrition, ESM Technologies, LLC, Biova LLC, Eggnovo S.L., Kewpie Corporation, Certified Nutraceuticals, Inc. and Seno Biotech are notable companies serving the defined eggshell membrane powder market.

Competition centers on three capabilities: access to clean eggshell side streams, controlled separation or hydrolysis, and the ability to support a repeatable ingredient specification with application evidence. Stratum Nutrition and ESM Technologies commercialize NEM and OVOLUX, Biova supplies water-soluble egg membrane ingredients, Eggnovo supplies Ovomet and related membrane ingredients, and Kewpie offers both powdered and hydrolyzed eggshell membrane formats. Certified Nutraceuticals and Seno Biotech add alternative hydrolyzed, powdered and egg-derived ingredient routes.

• Branded membrane specialists: Stratum Nutrition, ESM Technologies, Biova and Eggnovo compete through differentiated ESM formats, technical support and application evidence.
• Integrated egg-derived ingredient platforms: Kewpie and Seno Biotech combine eggshell membrane with broader egg-derived ingredient capabilities.
• Specialty ingredient suppliers: Certified Nutraceuticals and Seno Biotech compete through collagen-oriented or broader egg-derived functional ingredient portfolios.

Competitive Benchmarking: Eggshell Membrane Powder Market

Company	Direct Eggshell Membrane Portfolio	Soluble / Hydrolyzed Format Capability	Clinical / Regulatory Support	Geographic Reach
Stratum Nutrition	High	High	High	Multi-region
ESM Technologies, LLC	High	High	High	United States with international commercialization
Biova LLC	High	High	Medium	North America and distributor markets
Eggnovo S.L.	High	Medium	High	Europe and North America
Kewpie Corporation	High	High	Medium	Japan and international ingredient markets
Certified Nutraceuticals, Inc.	Medium	High	Medium	United States and export ingredient markets
Seno Biotech	High	Medium	Medium	China, Asia and international trade channels

Scoring basis: Direct Eggshell Membrane Portfolio reflects current branded or documented ESM ingredient offerings. Soluble / Hydrolyzed Format Capability reflects processing routes that increase formulation flexibility. Clinical / Regulatory Support reflects current human evidence, regulatory records, certifications or structured technical support tied to the ingredient platform. Geographic Reach reflects documented commercial presence or distribution routes. High indicates broad capability, while Medium indicates a narrower but established position.

Key Developments in the Eggshell Membrane Powder Market

• In July 2026, Commission Implementing Regulation (EU) 2026/1427 authorized Eggnovo S.L. as the sole company permitted to market enzymatically produced egg membrane hydrolysate as a novel food in the EU, with a five-year period of data exclusivity running from the regulation's entry into force on 23 July 2026. The authorization permits use in food supplements for the general adult population, excluding pregnant and breastfeeding women, at up to 500 mg per day.
• On September 23, 2025, Stratum Nutrition opened a new operational facility in Carthage, Missouri, citing growing demand for its proprietary ingredient portfolio including NEM eggshell membrane, OVOLUX and sageXtra sage extract. The expansion adds operational square footage proximate to the existing production site, with the stated aim of centralizing logistics and improving throughput capacity.
• In August 27, 2025, Biova LLC announced that BiovaPlex, its flagship natural joint health ingredient for pets, would include guaranteed minimum levels of collagen, elastin and glycosaminoglycans effective immediately. Biova cited support for joint, coat and connective tissue health in companion animals as the functional basis for standardizing the ingredient at these defined levels.

Key Players in the Eggshell Membrane Powder Market

Branded Eggshell Membrane Ingredient Specialists

• Stratum Nutrition
• ESM Technologies, LLC
• Biova LLC
• Eggnovo S.L.

Egg-Derived Ingredient Platforms

• Kewpie Corporation
• Seno Biotech

Specialty Functional Ingredient Suppliers

• Certified Nutraceuticals, Inc.

Eggshell Membrane Powder Market - Report Scope

Coverage field	Report scope
Market breakdown	Nature; Application
Quantitative Units	Revenue in USD Billion and CAGR in %.
Market Definition	Revenue includes sales of eggshell membrane powder and directly comparable membrane-derived powder grades sold into the stated Nature and Application categories. It excludes finished consumer products, eggshell calcium, non-membrane collagen ingredients, powder-processing equipment and contract processing revenue.
Regions Covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa
Countries Covered	USA, Canada, Japan, South Korea, Russia, France, Germany, Australia
Key Companies Profiled	Stratum Nutrition; ESM Technologies, LLC; Biova LLC; Eggnovo S.L.; Kewpie Corporation; Certified Nutraceuticals, Inc.; Seno Biotech
Forecast Period	2026 to 2036
Approach	Primary research and secondary research with market triangulation

Eggshell Membrane Powder Market - Research Methodology

Method	Approach
Primary Research	Interviews with ingredient manufacturers, processors, distributors, formulators, procurement teams and application specialists were used to understand purchasing criteria, specification requirements, adoption barriers, pricing considerations and technical-support expectations.
Desk Research	Desk research covered regulatory publications, scientific literature, trade data, industry associations, standards, company filings, current product information and official corporate announcements relevant to eggshell membrane powder.
Market Sizing and Forecasting	The market model combines baseline demand with segment structure, pricing and volume indicators, supplier participation, application adoption and country-level conditions. Forecast assumptions account for regulation, formulation activity, purchasing cycles, supply availability and barriers to wider use.
Data Validation	Estimates are compared across independent indicators and checked against the defined market boundary so adjacent finished products, unrelated collagen ingredients and overlapping revenue are not included in the market total.

Eggshell Membrane Powder Market by Segments

Eggshell Membrane Powder Market segmented by Nature:

• Conventional
• Organic

Eggshell Membrane Powder Market segmented by Application:

• Cosmetics & Personal Care
• Nutraceutical
• Food & Beverages
• Pharmaceutical

Eggshell Membrane Powder Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
  • Russia
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• European Commission (2026, July 2). Commission Implementing Regulation (EU) 2026/1427 authorising egg membrane hydrolysate as a novel food.
• U.S. Food and Drug Administration (2025, February 4; page updated 2026). GRN No. 1194: Partially hydrolyzed eggshell membrane powder derived from chicken eggs.
• Health Canada (2026, July 6). List of non-novel determinations for food and food ingredients: chicken eggshell membranes.
• Health Canada (2025-2026). Licensed Natural Health Products Database entries containing partially hydrolyzed chicken eggshell membrane.
• Therapeutic Goods Administration (2025, December 15). MagZorb Joint Ease with NEM, ARTG 521559.
• Therapeutic Goods Administration (2026, July 24). Youthology Glucosamine & Chondroitin, ARTG 529293.
• Ministry of Food and Drug Safety, Republic of Korea (2026). Regulation on Recognition of Functional Ingredient and of Standard and Specification for Health Functional Foods, No. 2026-33.
• Consumer Affairs Agency, Japan (2025). Updated guidance and notification materials for Foods with Function Claims.
• DGCCRF, France (2025, November 7). Labelling, presentation and advertising rules for food supplements.
• Rospotrebnadzor (2026, April 2). Oversight of biologically active food supplements.
• Zhang et al. (2026, April). Eggshell Membrane: Composition, Extraction, Functional Properties, and High-Value Applications in Functional Foods and Nutraceuticals.
• Park et al. (2025, April). Effects of oral supplementation with eggshell membrane on skin health: randomized, double-blind, placebo-controlled trial.
• Stratum Nutrition (2025, August 21). Eggshell membrane portfolio earns NutraStrong certification.
• Stratum Nutrition (2025, September 23). New Carthage, Missouri operational facility.
• Biova LLC (2025, August 27). BiovaPlex pet health ingredient specification update.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How big is the Eggshell Membrane Powder Market in 2026, and what value is forecast for 2036?
• What is supporting demand for eggshell membrane powder across joint-health and beauty applications?
• Why does Conventional lead the Nature category?
• Why does Cosmetics & Personal Care lead the Application category?
• How do the profiled country growth rates differ from 2026 to 2036?
• Which companies supply direct eggshell membrane powder or hydrolyzed membrane ingredients?
• What qualification issues can slow adoption or supplier switching?
• What should buyers evaluate before selecting an eggshell membrane powder grade?